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and 334 · 10 /μL, respectively)whereas, in comparisonwithHD, erythro-
cyte sedimentation rate (87 mm/h vs 2–20 mm/h in HD) and C-reactive
protein values (CRP; 20.19mg/dl vs 0–0.5mg/dl inHD)were signiﬁcantly
higher. At eighth day, for persistent fever and for suspected KD, the
patient received intravenous immunoglobulin (IVIG: two boluses
of 2 g/kg) and high-dose aspirin (100 mg/kg/day). Two days after
therapy the patient showed thrombocytosis (platelet number:
644 · 103/μL vs 150–450 · 103/μL) and a signiﬁcantly reduced number
of RBCs (3.72 · 106/μL vs 4.62 · 106/μL). After 18 days of hospitalization,
the patient was free of symptoms and either echocardiographic valuesKawasaki disease (KD) is a rare systemic vasculitis typical of the
early childhood. It is characterized by small- and medium-sized blood
vessel inﬂammation that can also lead to coronary artery weakening,
aneurysm formation, andmyocardial infarction. Therapywith immuno-
globulin and aspirin aims to reduce coronary artery inﬂammation. How-
ever, it has been hypothesized that, notwithstanding the efﬁcacy of the
pharmacological therapy, patients with regressed KD are at increased
risk to develop atherosclerosis after the acute illness.
In this work, the case of a 17-month-old child with KD was studied.
The patient was recruited from the Bambino Gesù Hospital of Rome
(Italy). Diagnosis of KD was based on the standard clinical criteria [1].
The study was conducted at admission of the patient (naïve patient)
and at follow-up. Five age-matched healthy donors (HD) were used
for each timepoint as controls. Informed consent byparentswas obtain-
ed. This study was approved from the Institutional Review Board of the
“Bambino Gesù” Hospital of Rome, Italy.
At admission, the patient reported fever since 5 days, and had urticar-
ial, a non-purulent conjunctivitis, cheilitis and a hyper-echogenicity of
coronary arteries without dilatation. Laboratory analyses showed: redità, Department of Therapeutic
g and Gender Medicine, Viale
tta.straface@iss.it (E. Straface).
land Ltd. This is an open access articlblood cell (RBC) and platelet counts in the normal range (4.26 · 106/μL
3
or CRP levels (1.36 mg/dl) were in the normal range, but RBC count was
still low (3.35 · 106/μL) and thrombocytosis was still detectable (platelet
number: 1.038 · 103/μL). The patient was discharged with the prescrip-
tion of an anti-aggregating therapy with aspirin (5 mg/kg/day for six
weeks). At follow-up, i.e.ﬁvemonths aswell asﬁve years after dismissing,
the patient showed normal coronary arteries, and also RBC and platelet
counts as well as CRP levels were in the normal range (4.62 · 106/μL,
390 · 103/μL, and 0.21 mg/dl, respectively).
Considering that the major risks in KD progression are the endothe-
lial dysfunction and cardiovascular fatal events [2], and that systemic
oxidative stress together with premature aging of RBCs could play a
critical role in the cardiovascular complications associated with KD [3],
we decided to evaluate, in naïve patient and at follow-up (5 months
and 5 years after dismissing) some peripheral blood redox-associated
parameters as well as RBC redox- and aging-associated features. In
particular, we focused our attention at: i) electron paramagnetic
resonance-detectable production of reactive oxygen- and nitrogen-
derived species (ROS) in the whole blood, measured by monitoring
the oxidation rate of 1-hydroxy-3-carboxypyrrolidine (CPH) spin
probe to the correspondent 3-carboxy-proxyl radical (vCP•) [3]; ii)
plasma antioxidant power (PAP) [4]; iii) plasmatic levels of asym-
metric dimethylarginine (ADMA, a speciﬁc endogenous inhibitor of
the NO synthase) [3]; and iv) plasmatic levels of myeloperoxidase
(MPO), a pro-oxidant enzyme [3]. In addition, by using static and
ﬂow cytometry, we evaluated RBC redox and aging markers, i.e.
ROS production, total thiol content, expression of glycophorin A
(GA, which is down-regulated during RBC senescence) and CD47
(thrombospondin receptor contributing to etherotypic adhesion
pattern). Furthermore, externalization of phosphatidylserine (PS)e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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and death also considered an adhesion molecule, was assessed [5].
Statistical analyses were performed by using Student's t-test. A p
value ≤ 0.05 was considered as signiﬁcant.
As concerns plasmatic measurements in the naïve patient, i.e. before
starting IVIG and aspirin therapy, in comparison with HD, the following
featureswere found: (i) a signiﬁcantly (p b 0.001) higher blood CPH ox-
idation rate and MPO levels (p b 0.001); (ii) signiﬁcantly (p b 0.001)
lower levels of PAP and ADMA (Fig. 1); (iii) normal values of lactate
dehydrogenase (LDH; 393 UI/L vs normal range 230–470 UI/L). Five
months and 5 years after dismissing, the levels of CPH oxidation, PAP,
ADMA and MPO reached values similar to those measured in plasma
from age-matched HD. Conversely, increased values of plasmatic
LDH were still detected at follow-up (475 UI/L after ﬁve months
and 527 UI/L after ﬁve years).
As concerns RBCs, in the naïve patient, with respect to HD, cytometric
analyses showed: i) no differences in ROS production, total thiol
content and CD47 expression; ii) a signiﬁcantly lower (p b 0.01)
GA expression, and iii) a signiﬁcantly (p b 0.05) higher percentage
of cells showing PS externalization (percentage of Annexin V posi-
tive cells) (Fig. 2).
Five months after dismissing, ROS levels in RBCs were unexpectedly
signiﬁcantly higher (p b 0.05), whereas total thiol content reached
values similar to those detected in RBCs from HD. In addition, GA ex-
pression, which was reduced at admission, was signiﬁcantly (p b 0.05)
increased, i.e. normal GA levels were restored. At variance, the percent-
age of Annexin V-positive RBCs was even increased in comparison with
admission values. Conversely, CD47 expression was signiﬁcantly lower
(p b 0.01) than in HD. Thus, in fewwords, ﬁve months after dismissing,Fig. 1. Redox parameters in the peripheral blood. Histograms± SD represent: (A) the rate of CP
and (D) MPO levels in plasma from the KD patient were evaluated in triplicate. vCP• was de
measured by using commercially available immunoassay kits. (°°°) indicates a signiﬁcant diffe
evaluated in triplicate (dashed lines). Note that, at follow-up, other values were in the normalRBCs still appeared oxidized and aged with respect to those detected at
admission or in RBCs from HD (Fig. 2).
Finally,ﬁve years after the onset of the disease, in the absence of clin-
ical manifestations, CD47 was overexpressed (three times higher than
in healthy donors). With respect to HD, no differences in ROS produc-
tion, total thiol content, GA expression and thepercentage of cells show-
ing PS externalization were instead found.
Summarizing, some recommendation seems to emerge from this
case report on the long-term management of patients with Kawasaki
disease, i.e. that the disappearance of clinical symptoms and the nor-
malization of some laboratory parameters should not be overestimated.
In particular, the overexpression of the adhesion-relatedmolecule CD47
on RBCs [6] and the high levels of serum LDH, recently considered a
marker of thrombosis risk, should be taken into account [7]. The possi-
bility that these laboratory data could represent critical factors or bio-
markers of cardiovascular risk in patients with this rare disease cannot
be ruled out. On these bases, the long termmonitoring of the patient de-
scribed here appears as mandatory.
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Fig. 2. Redox parameters in RBCs. Histograms± SD of median ﬂuorescence intensity indicate: (A) ROS production levels, (B) total thiol content, (C) GA expression levels, (E) CD47 expression
levels, and (F) the percentage of RBCs displaying PS externalization. These biomarkerswere evaluated in triplicate and compared to those obtained in RBCs from5HD (dashed lines). Note that:
i) no differenceswere detected in naïve patientwith respect to HD as concerns ROS levels, total thiol content and CD47 expression; ii) a very lowGA expression (°°p b 0.01 naïve patient vs HD)
and iii) a high percentage of RBCs with PS at the surface (°p b 0.05 naïve patient vs HD). To note that after 5 months: i) a signiﬁcant increase of ROS levels (*p b 0.05 vs naïve patient);
a signiﬁcantly higher expression of GA (*p b 0.05 vs naïve patient); a very low expression of CD47 (*p b 0.05 vs naïve patient); and a high percentage of RBCs showing PS externalization
(**p b 0.01 vs naïve patient) were detected. At 5 years of follow-up, with respect to naïve patient, an overexpression of CD47 (**p b 0.01) was detectable. Two representative micrographs
obtained by static cytometry showing GA distribution in RBCs from naïve patient (left panel) and at 5 years of follow-up (right panel) are shown in (D).
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